VeriMomsymphytum officinale root extract é seguro durante a gravidez?
Symphytum officinale (comfrey) root/leaf extracts contain pyrrolizidine alkaloids (PAs) that are hepatotoxic, genotoxic and associated with carcinogenicity and reported fetal/veno‑occlusive effects; regulatory bodies caution against internal use in pregnancy and some authorities advise avoiding topical use in pregnancy because of PA-related risks (EMA monograph; PubMed reviews). Skin‑permeation studies show PAs are poorly absorbed through intact human skin but measurable, so topical exposure is low but not zero. (Sources: EMA herbal monograph; PubMed review of Symphytum species; human skin permeation study).
Pregnancy-safe products containing symphytum officinale root extract
Alternativas seguras ao symphytum officinale root extract na gravidez | VeriMom
Related ingredients
Frequently asked questions
- symphytum officinale root extract é seguro durante a gravidez?
- Symphytum officinale (comfrey) root/leaf extracts contain pyrrolizidine alkaloids (PAs) that are hepatotoxic, genotoxic and associated with carcinogenicity and reported fetal/veno‑occlusive effects; regulatory bodies caution against internal use in pregnancy and some authorities advise avoiding topical use in pregnancy because of PA-related risks (EMA monograph; PubMed reviews). Skin‑permeation studies show PAs are poorly absorbed through intact human skin but measurable, so topical exposure is low but not zero. (Sources: EMA herbal monograph; PubMed review of Symphytum species; human skin permeation study).
- symphytum officinale root extract é seguro durante a amamentação?
- Because PAs in comfrey are hepatotoxic and have been implicated in infant toxicity and are discouraged during lactation, breastfeeding is cautioned; dermal/topical exposure can result in measurable but low absorption and there are case reports and regulatory warnings advising avoidance with nursing due to risk to the suckling infant. Mechanism is PA metabolic activation with genotoxic/hepatotoxic effects. (Sources: EMA monograph; regulatory advisories; PubMed reviews).
- symphytum officinale root extract é seguro para a pele do bebê?
- Infants (0–3 yr) have higher skin permeability and higher surface‑area‑to‑weight, so exposure score is increased. Given comfrey’s content of pyrrolizidine alkaloids (hepatotoxic/genotoxic), and documented infant/fetal cases and regulatory cautions (including advice to avoid use on nursing mothers and infants), residual PA on skin or transfer via breast/chest application could pose risk; although dermal PA absorption was shown to be low in one ex vivo study, infant susceptibility and cases justify conservative approach. (Sources: PubMed review; skin permeation study; regulatory guidance).
- Como o VeriMom pontua symphytum officinale root extract?
- O VeriMom pontua symphytum officinale root extract em 40/100 (risco médio) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
- Quais são as alternativas seguras a symphytum officinale root extract na gravidez?
- Veja nossa lista curada de alternativas seguras a symphytum officinale root extract com base em função semelhante e classificação sem riscos conhecidos.
Verifique qualquer rótulo em 2 segundos
Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.
Aviso Médico
Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.